Print

5 Reasons to Choose Meltdose

Choose the technology that makes sense for your patients and your business and is:

Clinically Proven

  • The ability of MeltDose® technology to increase bioavailability and/or reduce food effect has been confirmed in numerous clinical studies with a range of poorly soluble compounds

Commercially Viable

  • The first MeltDose® based product, Fenoglide®, is approved by the FDA and marketed in the US
  • MeltDose® based product candidates are in late stage development and have already been manufactured on a commercial scale
  • The MeltDose® manufacturing process has been inspected by the FDA and is fully validated in commercial scale
  • The approval process is facilitated by the fact that MeltDose® uses exclusively GRAS excipients

Patent Protected

  • MeltDose® basic process patents provide coverage until 2022
  • MeltDose® may provide an efficient tool for lifecycle management of marketed products

Scalable and Transferable

  • MeltDose® employs conventional manufacturing equipment, does not require significant additional investment and is easily scalable to commercial batch sizes
  • LCP can offer a custom made technology transfer program to allow you to manufacture your own MeltDose® based products
  • MeltDose® manufacturing process has already been established at leading CMOs in both Europe and USA

Cost Effective and Flexible

  • The cost of goods of the MeltDose® based tablets is comparable to that of conventional plain tablets
  • MeltDose® can be used to create customized release profiles including immediate or controlled release and is suitable for enteric coating
  • MeltDose® is a solvent-free, one-step process that can also be carried out in an inert atmosphere. The resulting granulate is suitable for direct compression to tablets